Activation of mTOR, AKT and loss of PTEN have each been associated with a poorer prognosis in lung cancer patients [5, 6], however an association between PIK3CA mutation status and prognosis has been controversial [6]. This evidence concerns the gene PIK3CA and lung cancer.